You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

Article metrics

Article menu

Download PDFPDF

XML
Research Article
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019770
Jan 202018180
Feb 202038383
Mar 202045454
Apr 202054541
May 202070703
Jun 2020363624
Jul 2020252511
Aug 2020292912
Sep 2020494951
Oct 2020595929
Nov 2020555632
Dec 2020666626
Jan 2021424241
Feb 2021535332
Mar 2021363626
Apr 2021585844
May 2021474738
Jun 2021454529
Jul 2021424222
Aug 2021686833
Sep 2021767743
Oct 2021535346
Nov 2021575643
Dec 2021292916
Jan 2022404323
Feb 2022343726
Mar 2022515645
Apr 2022939530
May 2022383938
Jun 2022464927
Jul 2022525320
Aug 2022404013
Sep 2022424424
Oct 2022595928
Nov 2022808546
Dec 2022505119
Jan 2023676729
Feb 2023939330
Mar 202311912254
Apr 2023727828
May 2023606128
Jun 2023646541
Jul 2023858536
Aug 2023828340
Sep 202311911928
Oct 202325025330
Nov 202350550825
Dec 2023747426
Jan 2024656538
Feb 2024717128
Mar 2024969743
Apr 202410911042
May 202410210229
Jun 2024717131
Jul 2024838324
Aug 2024717328
Sep 2024777726
Oct 2024777740
Nov 202410410540
Dec 202411011133
Jan 202510010062
Feb 2025575739
Mar 2025788051
Apr 2025798036
May 2025969644
Jun 2025848663
Jul 2025110
Total490349592040